Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
O00399
UPID:
DCTN6_HUMAN
Alternative names:
Dynactin subunit p27; Protein WS-3
Alternative UPACC:
O00399; B2RAC1
Background:
Dynactin subunit 6, also known as Dynactin subunit p27 or Protein WS-3, is a crucial component of the dynactin complex. This complex plays a pivotal role in activating the molecular motor dynein, facilitating ultra-processive transport along microtubules. Such transport is essential for a variety of cellular processes, including mitosis, signaling, and intracellular trafficking.
Therapeutic significance:
Understanding the role of Dynactin subunit 6 could open doors to potential therapeutic strategies. Its involvement in fundamental cellular processes underscores its potential as a target for drug discovery, aiming to modulate cellular transport mechanisms in disease states.